Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists

References

• European Generic Medicines Association. Generic medicines: a cornerstone of EU healthcare policy. Brussels: EGA [cited 2015 Aug 26]. Available from: http://www.egagenerics.com/images/Website/003_EGA_FS_Generic_medicines_Web.pdf
   Google Scholar
• King DR, Kanavos Р. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43:462–469.
   PubMed Web of Science ®Google Scholar
• Garattini L, Tediosi F. A comparative analysis of generic markets in five European countries. Health Policy. 2000;51:149–162.
   Google Scholar
• Simoens S. Sustainable provision of generic medicines in Europe [Internet]. Brussels: European Generic Medicines Association; 2013 [cited 2015 Nov 10]. Available from: http://www.quotidianosanita.it/allegati/allegato3090824.pdf
   Google Scholar
• Perkins MB, Jensen PS, Jaccard J, et al. Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know? Psychiatr Services. 2007;58:342–348.
   PubMed Web of Science ®Google Scholar
• Swan J, Combs J. Product performance and consumer satisfaction: a new concept. J Mark. 1976;40:25–33.
   Web of Science ®Google Scholar
• Cadotte ER, Turgeon N. Dissatisfiers and satisfiers: suggestions for consumer complaints and compliments. J Cons Satisf Dissatisf Compl Behav. 1988;1:74–79.
   Google Scholar
• Rust RT, Zahoric AJ. Customer satisfaction, customer retention, and market share. J Retail. 1993;2:193–215.
   Web of Science ®Google Scholar
• Peikova L, Manova M, Georgieva S, et al. Enantiomers novelty protection and its influence on generic market: an example with escitalopram patent protection. Biotechnol Biotechnol Equip. 2013;27(4):4044–4047.
   Web of Science ®Google Scholar
• Dylst P, Vulto A, Simoens S. Demand-side policies to encourage the use of generic medicines: an overview. Expert Rev Pharmacoecon Outcomes Res. 2013;13:59–72.
   PubMed Web of Science ®Google Scholar
• Lofgren H. Generic drugs: international trends and policy developments in Australia. Aust Health Rev. 2004;27(1):39–48.
   PubMedGoogle Scholar
• Dylst P, Simoens S. Generic medicine pricing policies in Europe: current status and impact. Pharmaceuticals. 2010;3(3):471–481.
   Google Scholar
• Dunne S, Shannon B, Hannigan A, et al. Physician and pharmacist perceptions of generic medicines: what they think and how they differ? Health Policy. 2014;116:214–223.
   PubMed Web of Science ®Google Scholar
• Finnegan PM, Gleason BL. Combination ACE inhibitors and angiotensin II receptor blockers for hypertension. Ann. Pharmacother. 2003;37(6):886–889.
   PubMed Web of Science ®Google Scholar
• Wald SD, Malcolm L, Joan KM, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 1999;122(3):290–300.
   Google Scholar
• Van Vark LC, Bertrand M, Akkerhuis K, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. Eur Heart J. 2012;33(16):2088–2097.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Salukhe TV, Coats AJ, et al. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol. 2004;92(2):105–111.
   Web of Science ®Google Scholar
• Mott DA, Richard CR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–674.
   PubMed Web of Science ®Google Scholar
• Kesselheim A, Misono A, Lee J, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a meta-analysis. JAMA. 2008;300(21):2514–2526.
   PubMed Web of Science ®Google Scholar
• Cadotte ER, Woodruff RB, Jenkins RL. Expectations and norms in models of consumer satisfaction. J Mark Res. 1987;24:305–314.
   Web of Science ®Google Scholar
• Holsclaw SL, Olson KL, Hornak R, et al. Assessment of patient satisfaction with telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction service. J Manag Care Pharm. 2005;11:403–409.
   PubMedGoogle Scholar
• Oparah AC, Kikanme LC. Consumer satisfaction with community pharmacies in Warri, Nigeria. Res Social Adm Pharm. 2006;2:499–511.
   PubMedGoogle Scholar
• Chandra A, Finlay JB, Paul DP 3rd. Overall outpatient satisfaction and its components: perceived changes at the Huntington VA Medical Center over five years. Hosp Top. 2006;84:33–36.
   PubMedGoogle Scholar
• Hayashi S, Hayase T, Ikegami N, et al. Comparison of viewpoints and awareness between patients with and without a “family pharmacy.” Yakugaku Zasshi. 2006;126:123–131.
   PubMed Web of Science ®Google Scholar
• Clerfeuille F, Poubanne Y. Differences in the contributions of elements of service to satisfaction, commitment and consumer's share of purchase: a study from the tetra-class model. J Target Meas Anal Market. 2003;1:66–81.
   Google Scholar
• Clerfeuille F, Poubanne Y, Vakrilova M, et al. Evaluation of the consumer's satisfaction using the tetra-class model. Res Social Adm Pharm. 2008;4(3):258–271.
   PubMed Web of Science ®Google Scholar
• Bartikowski B, Llosa S. De la théorie du poids fluctuant des éléments dans la satisfaction à la mesure. Comparaison empirique de quatre méthodes, Actes de la Conférence de l'Association Française du Marketing [ The theory of the relative weight of the elements in satisfaction measurement. Empirical comparison of four methods. Issue from the Conference of French Marketing Association, IAE de Caen-Basse Normandie]. Deauville: IAE de Caen-Basse Normandie; 2001.
   Google Scholar
• Llosa S. L'analyse de la contribution des éléments du service à la satisfaction: un modèle tétra-classe [Analysis of the contribution of elements of services on satisfaction: a tetra-class model]. Décisions Market. 1997;10:81–88.
   Google Scholar
• Hayashi S, Hayase T, Mochizuki M, et al. Classification of pharmaceutical services from the viewpoint of patient satisfaction/dissatisfaction. Yakugaku Zasshi. 2005;125:159–168.
   PubMed Web of Science ®Google Scholar
• Garbarino E, Johnson MS. The different roles of satisfaction, trust, and commitment in customer relationships. J Mark. 1999;63:70–87.
   Web of Science ®Google Scholar
• O'Riordan M. One pill to cure them all: single-drug polypharmacy in cardiovascular disease [Internet]. Hamilton, Ontario: Medscape; 2012 [cited 2014 Aug 5]. Available from: http://www.medscape.com/viewarticle/771801
   Google Scholar
• Figueiras MJ, Marcelino D, Cortes MA. People's views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–594.
   PubMed Web of Science ®Google Scholar
• Heikkila R, Mantyselka P, Hartikainen-Herranen K, et al. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82:366–374.
   PubMed Web of Science ®Google Scholar
• Quintala C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104:61–68.
   PubMed Web of Science ®Google Scholar